Fadi J. Charchar

18.2k citations

117 papers · 6.2k indexed · 2 hit papers · h-index 34

Cardiology and Cardiovascular Medicine top 0.5%
Molecular Biology top 5%
Physiology top 2%
Endocrinology, Diabetes and Metabolism top 1%
Surgery top 5%

Co-authors: Maciej Tomaszewski Bryan Williams Markus P. Schlaich Aletta E. Schutte Neil R Poulter Claudio Borghi Richard D. Wainford Agustín J. Ramiréz
Topics: Hormonal Regulation and Hypertension (15 papers)Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (12 papers)MicroRNA in disease regulation (12 papers)
Cited by: Cardiology and Cardiovascular Medicine Aging Endocrinology, Diabetes and Metabolism
Journals: The Lancet Circulation PLoS ONE
Partner nations: Australia United Kingdom Poland

In The Last Decade

Fadi J. Charchar

114 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2020 International Society of Hypertension Global Hypertension Practice Guidelines

2020 2.3k citations Fadi J. Charchar, Maciej Tomaszewski et al. Hypertension profile →
2020 International Society of Hypertension global hypertension practice guidelines

2020 713 citations Fadi J. Charchar, Maciej Tomaszewski et al. profile →

Peers

Countries citing papers authored by Fadi J. Charchar

Since Specialization

Citations

This map shows the geographic impact of Fadi J. Charchar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fadi J. Charchar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fadi J. Charchar more than expected).

Fields of papers citing papers by Fadi J. Charchar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fadi J. Charchar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fadi J. Charchar. The network helps show where Fadi J. Charchar may publish in the future.

Co-authorship network of co-authors of Fadi J. Charchar

This figure shows the co-authorship network connecting the top 25 collaborators of Fadi J. Charchar. A scholar is included among the top collaborators of Fadi J. Charchar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fadi J. Charchar. Fadi J. Charchar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Four-week inhibition of the renin–angiotensin system in spontaneously hypertensive rats results in persistently lower blood pressure with reduced kidney renin and changes in expression of relevant gene networks 2024 ·Cardiovascular Research ·Sean Byars,Priscilla R. Prestes,(unknown),Fumihiko Takeuchi,(unknown),(unknown),Mariana Melo,David J. Balding,Nilesh J. Samani,Andrew M. Allen,Norihiro Kato,Jennifer L. Wilkinson‐Berka,Fadi J. Charchar,Stephen Harrap	1
2	Dietary fatty acids and mortality risk from heart disease in US adults: an analysis based on NHANES 2023 ·Scientific Reports ·Yutang Wang,(unknown),Paul K. Witting,Fadi J. Charchar,Christopher G. Sobey,Grant R. Drummond,Jonathan Golledge	23
3	Telomere Therapy for Chronic Kidney Disease 2022 ·Epigenomics ·(unknown),(unknown),James Eales,Maciej Tomaszewski,Fadi J. Charchar	12
4	Kidney omics in hypertension: from statistical associations to biological mechanisms and clinical applications 2022 ·Kidney International ·Maciej Tomaszewski,Andrew P. Morris,Joanna M. M. Howson,Nora Franceschini,James Eales,Xiaoguang Xu,Sergey Dikalov,Tomasz J. Guzik,Benjamin D. Humphreys,Stephen Harrap,Fadi J. Charchar	8
5	Contributions of obesity to kidney health and disease: insights from Mendelian randomization and the human kidney transcriptomics 2021 ·Cardiovascular Research ·Xiaoguang Xu,James Eales,Xiao Jiang,Eleanor Sanderson,(unknown),Sushant Saluja,(unknown),Bryan Williams,Andrew P. Morris,Tomasz J Guzik,Fadi J. Charchar,Michael V. Holmes,Maciej Tomaszewski	22
6	A Modified MTS Proliferation Assay for Suspended Cells to Avoid the Interference by Hydralazine and β-Mercaptoethanol 2021 ·Assay and Drug Development Technologies ·Yutang Wang,(unknown),Guang Yang,(unknown),(unknown),Zhonglin Chai,(unknown),Fadi J. Charchar,Jonathan Golledge	16
7	Deficiency of MicroRNA-181a Results in Transcriptome-Wide Cell-Specific Changes in the Kidney and Increases Blood Pressure 2021 ·Hypertension ·(unknown),Kristy L. Jackson,Malathi S.I. Dona,(unknown),Bruna Visniauskas,Anna M.D. Watson,Chad Johnson,Minolfa C. Prieto,Roger G. Evans,Fadi J. Charchar,Alexander R. Pinto,Francine Z. Marques,Geoffrey A. Head	8
8	Secondary Stroke Prevention in Polish Adults: Results from the LIPIDOGRAM2015 Study 2021 ·Journal of Clinical Medicine ·Beata Łabuz-Roszak,Maciej Banach,Michał Skrzypek,Adam Windak,Tomasz Tomasik,Mirosław Mastej,Maciej Tomaszewski,Dimitri P. Mikhailidis,Peter P. Tóth,Alberico L. Catapano,Kausik K. Ray,George Howard,Gregory Y.H. Lip,Fadi J. Charchar,Naveed Sattar,Bryan Williams,Thomas M. MacDonald,Peter E. Penson,Jacek Jerzy Jozwiak,(unknown)	5
9	An Improved 3-(4,5-Dimethylthiazol-2-yl)-5-(3-Carboxymethoxyphenyl)-2-(4-Sulfophenyl)-2H-Tetrazolium Proliferation Assay to Overcome the Interference of Hydralazine 2020 ·Assay and Drug Development Technologies ·Yutang Wang,(unknown),Guang Yang,(unknown),Zhonglin Chai,Fadi J. Charchar,Jonathan Golledge	9
10	Telomere Length Maintenance and Cardio-Metabolic Disease Prevention Through Exercise Training 2016 ·Sports Medicine ·Joshua Denham,B O’Brien,Fadi J. Charchar	63
11	Measurement of absolute copy number variation reveals association with essential hypertension 2014 ·BMC Medical Genomics ·Francine Z. Marques,Priscilla R. Prestes,Leonardo Pinheiro,Katrina J. Scurrah,Kerry R. Emslie,Maciej Tomaszewski,Stephen Harrap,Fadi J. Charchar	17
12	Coronary artery disease predisposing haplogroup I of the Y chromosome, aggression and sex steroids – Genetic association analysis 2014 ·Atherosclerosis ·Lisa D.S. Bloomer,Christopher P. Nelson,Matthew Denniff,Paraskevi Christofidou,Radosław Dębiec,John R. Thompson,E Zukowska-Szczechowska,Nilesh J. Samani,Fadi J. Charchar,Maciej Tomaszewski	16
13	Consumption of a low glycaemic index diet in late life extends lifespan of Balb/c mice with differential effects on DNA damage 2013 ·PubMed ·(unknown),(unknown),Fadi J. Charchar,(unknown),Paul Lewandowski	8
14	Urotensin-II System in Genetic Control of Blood Pressure and Renal Function 2013 ·PLoS ONE ·Radosław Dębiec,Paraskevi Christofidou,Matthew Denniff,Lisa D.S. Bloomer,Paweł Bogdański,(unknown),Katarzyna Musialik,Fadi J. Charchar,John R. Thompson,Dawn Waterworth,Kijoung Song,Péter Vollenweider,Gérard Waeber,E Zukowska-Szczechowska,Nilesh J. Samani,David G. Lambert,Maciej Tomaszewski	12
15	Genetic Dissection of a Blood Pressure Quantitative Trait Locus on Rat Chromosome 1 and Gene Expression Analysis Identifies SPON1 As a Novel Candidate Hypertension Gene 2007 ·Circulation Research ·(unknown),Richard J. Dixon,(unknown),(unknown),Bhakti Patel,Laurence S. Hall,Ming Lo,J Sassard,Fadi J. Charchar,Nilesh J. Samani	30
16	Glomerular hyperfiltration: A new marker of metabolic risk 2007 ·Kidney International ·Maciej Tomaszewski,Fadi J. Charchar,Christine Maric,John McClure,(unknown),W Grzeszczak,Naveed Sattar,E Zukowska-Szczechowska,Anna F. Dominiczak	189
17	Comparative and functional analyses of LYL1 loci establish marsupial sequences as a model for phylogenetic footprinting☆ ☆Sequence data from this article have been deposited with the DDBJ/EMBL/GenBank Data Libraries under Accession No. AL731834. 2003 ·Genomics ·Michael A. Chapman,Fadi J. Charchar,Sarah Kinston,Christine Bird,Darren Grafham,Jane Rogers,Frank Grützner,Jennifer A. Marshall Graves,Anthony R. Green,Berthold Göttgens	47
18	Cardiovascular diseases and G-protein β3 subunit gene (GNB3) in the era of genomewide scans 2003 ·Journal of Human Hypertension ·Maciej Tomaszewski,Fadi J. Charchar,Sandosh Padmanabhan,E Zukowska-Szczechowska,W Grzeszczak,Anna F. Dominiczak	2
19	Independent Y chromosome markers associated with blood pressure and testosterone levels 2002 ·Fadi J. Charchar,Maciej Tomaszewski,Sandosh Padmanabhan,B Łacka,Nathan Anderson,E Zukowska-Szczechowska,W Grzeszczak,Anna F. Dominiczak	1
20	LOW AFFINITY NERVE GROWTH FACTOR RECEPTOR GENE CO‐SEGREGATES WITH DECREASED BODYWEIGHT AND INCREASED LEFT VENTRICULAR WEIGHT IN SPONTANEOUSLY HYPERTENSIVE RATS 1996 ·Clinical and Experimental Pharmacology and Physiology ·(unknown),Kiyomitsu Nemoto,Takashi Ueyama,Fadi J. Charchar,Haruaki Kageyama,(unknown),Masashi Sekimoto,Emiko Senba,Takako Tomita,Ikuyoshi Tomita,Stephen Harrap	1

About Fadi J. Charchar

Fadi J. Charchar is a scholar working on Aging, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine, having authored 117 papers that have together received 6.2k indexed citations. Recurring topics across this work include Hormonal Regulation and Hypertension (15 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (12 papers) and MicroRNA in disease regulation (12 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (2.2k citations), Aging (156 citations) and Endocrinology, Diabetes and Metabolism (953 citations). Fadi J. Charchar has collaborated with scholars based in Australia, United Kingdom and Poland. Frequent co-authors include Maciej Tomaszewski, Bryan Williams, Markus P. Schlaich, Aletta E. Schutte, Neil R Poulter, Claudio Borghi, Richard D. Wainford, Agustín J. Ramiréz, George S. Stergiou and Thomas Unger. Their work appears in journals such as The Lancet, Circulation and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact